Affymetrix Inc., (Nasdaq:AFFX) announced today that scientists at Cancer Research UK have used Affymetrix technology to discover the molecular basis for tamoxifen response in breast cancer cells – and the reason why some women can develop resistance to the treatment. Their findings are published in Nature1. Tamoxifen is given to most women for five years […]
SOUTH EASTON, Mass., Dec. 1 — Pressure BioSciences, Inc. (Nasdaq: PBIO – News; “PBI” or the “Company”) today announced a comprehensive restructuring program designed to significantly reduce costs, centralize core operations, and refocus the Company’s business strategy in specific areas where the Company’s products have found significant market acceptance. The restructuring program includes: — a […]
Asuragen, Inc. announced today the launch of its BCR/ABL1 Quant (RUO)* kit, a research tool utilizing multiplex real-time quantitative RT-PCR to provide simultaneous detection and quantification of BCR/ABL1 fusion transcripts (b2a2, b3a2, and e1a2), ABL1 (an endogenous control), and BCR/ABL1Quant Norm (an exogenous control) in a single reaction. The kit is based on TaqMan® technology […]
Biocitech Life Sciences Park, France – Cellectis S.A. (Alternext: ALCLS), the genome engineering company for therapeutic, life science research and other biotechnology industries, announced today the achievement of a key milestone set at the time of its 2007 IPO. The company also provides an update on its objectives and timeline. By reaching the 20 meganucleases […]
PARIS, November 28 — ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray(TM) for use in studying mouse models of human disease. These SpliceArray(TM) products help our clients accelerate and refine their therapeutic target discovery and validation efforts. Using our high resolution expression profiling analysis, […]
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the appointment of Achim von Leoprechting, Ph.D., as vice president and general manager, cellular imaging and analysis solutions. In this role, Dr.von Leoprechting will be responsible for driving the cellular imaging business for PerkinElmer. Dr. von Leoprechting […]
Accelerated Technology Laboratories, Inc. (ATL) is pleased to announce the addition of Dr. Thomas Klinckman to the rapidly expanding Laboratory Information Management System (LIMS) Implementation team. Dr. Klinckman comes to ATL with over 15 years of experience in laboratory operations and laboratory automation. Previously, he served as the Laboratory Manager at Energy Northwest in Richland, […]
Toronto, CA (November 25, 2008)—Sanofi-Aventis, one of the world’s leading pharmaceutical companies, recently agreed to a three-year contract to extend the use of Advanced Chemistry Development, Inc., (ACD/Labs) software throughout its R&D sites worldwide. The agreement includes provisions for continuing support, and a special pricing structure beneficial to both companies. Sanofi-Aventis uses a range of […]
ST. LOUIS, Nov. 25 — Sigma-Aldrich (Nasdaq: SIAL) announced today it has entered into a research collaboration program with D-Finitive Cell Technologies, Inc. This collaboration is expected to support the development and commercial offering of 14 products over a two-year span, with a planned launch of many of these products in 2009. These additions to […]
Improves Quantitative Analysis of Differences in Protein Abundance Between Samples GE Healthcare has introduced DeCyder™ 2D 7.0, a new software package for analysis of 2-D Fluorescence Difference Gel Electrophoresis (2-D DIGE) experiments. 2-D DIGE is a powerful tool for detection and quantitation of real biological differences in protein abundance between different samples. DeCyder 2D 7.0 […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
